Scientific evidence is not meant to be taken personally, it’s not meant to hurt your feelings, it’s not meant to judge your character. Scientific evidence serves to either support or counter a hypothesis, and be critically evaluated in a systematic way using consistent logic.

When you and your rescue dog both accidentally match the aesthetic of Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 gorgeous backyard 🖤🤍🖤🤍 Kaya really went from living on the streets to the gourmet treats, real quick 😂

Fortunately, no one uses it anymore, but just in case this is from the NIH How excess niacin may promote cardiovascular disease -- nih.gov/news-events/ni… National Lipid Association European Atherosclerosis Society

Dr. Belardo and I discuss the new advances in treating Lp(a), one of which #olpasiran reduces levels one year after drug discontinuation in the OCEAN(a)-DOSE trial.

Viet Le DMSc PA-C FACC FAHA HF-Cert Danielle Belardo, MD Khurram Nasir Ryan Cooley, MD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 C. Michael Gibson MD Michael D. Shapiro Thomas Dayspring John P Erwin III MD MBA FACC Alison L. Bailey, MD Dr. Purvi Parwani Rob Ostfeld, MD, MSc John Mandrola, MD Ron Blankstein I consider pts w/CAC>1000 a very high risk cohort 👇🏽👇🏽 ahajournals.org/doi/10.1161/CI…

Danielle Belardo, MD Khurram Nasir Ryan Cooley, MD C. Michael Gibson MD Viet Le DMSc PA-C FACC FAHA HF-Cert Michael D. Shapiro Thomas Dayspring John P Erwin III MD MBA FACC Alison L. Bailey, MD Dr. Purvi Parwani Rob Ostfeld, MD, MSc John Mandrola, MD Ron Blankstein Very predictive!!! But like so many we find them after disease has started. If we checked Lp(a) early and lipids early we would find and treat patients earlier. Family Heart Foundation

Patient in their 30’s w/confirmed HeFH (testing), baseline LDL-C 195 mg/dL, elevated Lp(a) 70 mg/dL, and FmHx of early ascvd (MI in 40’s). CAC 0 (😊). hsCRP <2.0. A1c <5.5%. Active, follows plant-based diet. What LDL-C do you recommend they achieve:

A moment for the dress (one of my favorites this summer ☺️)

Saw this on instagram: misinformation & misinterpretation of data 🚨HRT is not used for #CVprev, the data does not support that & there remains a black box warning on HRT🚨 We will be debating this at #ESCCongress but no guidelines support HRT for🫀prev! Jennifer Gunter Danielle Belardo, MD

August 28 - life-changing day for me in 2018. Got blood drawn, scrubbed into a long case. WBC 0.9 Hgb 7.1 Plt 11 Myelodysplastic syndrome. Allo BMT 2019, still in remission👍 Infinite gratitude to my family, friends & co-workers & especially my docs (Dr. Loren and Dr. Porter)❤️

Loving that we are realizing the BMI paradox way less important than visceral fat deposition for risk for HFpEF. A super session here with Amina and my HFpEF co-author Matthew Lee #ESCCongress2024

Patients will like the #SCOFF trial from #ESCCongress2024! Fasting 🆚nonfasting prior to cath: noninferior priory endpoint (hypotension,aspiration pneumonia, hyperglycemia & hypoglycemia until discharge) Do patients still need to fast pre cath?

Really excited to see this data come out! Nice also to have therapies that have this evidence behind it! #ESCCongress #plozasiran #chylomicronemia

Heterogeneity exists in subclinical ath across LDL-C, CAC and estimated 🫀 risk levels. The value of CCTA in risk-stratifying asymptomatic 👫 could be explored further 🔗atherosclerosis-journal.com/article/S0021-… Khurram Nasir Reed Mszar Miguel Cainzos-Achirica Michael D. Shapiro Jonathan Fialkow Sadeer Al-Kindi, MD

Prevention requires bold & forward-thinking investments. My OpEd on why letting funding lapse for AllofUsResearch would be a step backwards statnews.com/2024/09/03/all… STAT